2 code implementations • 5 Mar 2024 • Brenda Y. Miao, Irene Y. Chen, Christopher YK Williams, Jaysón Davidson, Augusto Garcia-Agundez, Shenghuan Sun, Travis Zack, Suchi Saria, Rima Arnaout, Giorgio Quer, Hossein J. Sadaei, Ali Torkamani, Brett Beaulieu-Jones, Bin Yu, Milena Gianfrancesco, Atul J. Butte, Beau Norgeot, Madhumita Sushil
Recent advances in generative models, including large language models (LLMs), vision language models (VLMs), and diffusion models, have accelerated the field of natural language and image processing in medicine and marked a significant paradigm shift in how biomedical models can be developed and deployed.
1 code implementation • Journal of Biomedical Informatics 2023 • Gino Tesei, Stefanos Giampanis, Jingpu Shi, Beau Norgeot
The primary difference between causal effect studies utilizing observational data and RCTs is that for observational data, the study occurs after the treatment, and therefore we do not have control over the treatment assignment mechanism.
Ranked #1 on Causal Inference on Jobs
no code implementations • 29 Sep 2021 • Jingpu Shi, Dong Wang, Gino Tesei, Beau Norgeot
Validation of these models, however, has been a challenge because the ground truth is unknown: only one treatment-outcome pair for each person can be observed.
no code implementations • 29 Sep 2021 • Gino Tesei, Stefanos Giampanis, Beau Norgeot
Additionally, we show that error improvements between our approach and previously published state-of-art methods widen as a function of sample dissimilarity between treated and untreated covariate distributions.
no code implementations • BMC Medical Research Methodology 2021 • Chinmay Belthangady, Will Stedden, Beau Norgeot
Observational studies are increasingly being used to provide supplementary evidence in addition to Randomized Control Trials (RCTs) because they provide a scale and diversity of participants and outcomes that would be infeasible in an RCT.
Ranked #6 on Causal Inference on IHDP
no code implementations • 30 Nov 2018 • Beau Norgeot, Dmytro Lituiev, Benjamin S. Glicksberg, Atul J. Butte
Clinical data for ambulatory care, which accounts for 90% of the nations healthcare spending, is characterized by relatively small sample sizes of longitudinal data, unequal spacing between visits for each patient, with unequal numbers of data points collected across patients.